Dr. Trevor Collingwood

Biography

Trevor brings over a decade of experience in the field of genome editing and its application. He has operated in key roles in R&D, business development, marketing and alliance management for early stage development of genome editing technologies at leading companies in the field, including Sangamo Biosciences, CRISPR Therapeutics and Sigma-Aldrich. Trevor received his D.Phil. in Biochemistry from the University of Waikato, New Zealand, followed by post-doctoral studies at University of Cambridge, UK, and the National Institutes of Health, USA.

Research Interest

genome